Javascript must be enabled to continue!
Changes and determinants of pneumococcal vaccine uptake in Ethiopia
View through CrossRef
Abstract
Background:
Pneumococcal pneumonia is one of the most common causes of severe pneumonia and pneumonia-related mortality globally. It is one of the top five causes of mortality and mortality in children under five in Ethiopia. Vaccinating children reduced the disease burden of pneumonia and death-related pneumococcal infection for both child and adult populations. Pneumococcal Pneumonia is one of the vaccine-preventable diseases.
Objective: To assess how pneumococcal vaccine uptake changes over time and to identify factors associated with uptake of the pneumococcal vaccine.
Data: This study was conducted based on secondary data obtained from the Ethiopian Demographic and Health Surveys (EDHS) conducted in 2016 and 2019, two nationally representative surveys. A total of 1929 and 1008 children of aged 12–23 months were included res from the 2016 and 2019 Demographic and Health Surveys respectively.
Method: The Percentage change in pneumococcal vaccine (PCV) coverage was used to quantify the degree of change over time. To identify the significant factors associated with the uptake of PCV vaccines, a multilevel ordinal logistic regression model was used. All statistical tests were run with a significance threshold of 5%.
Result:The percentage of children aged 12-23 months who received complete doses of PCV vaccination increased from 49.1% in 2016 to 59.8% in 2019 with a significant 21.8% increase [95% CI: 9.8-35.2]. Children in rural areas are 69% less likely to receive more doses of PCV vaccinations than those who live in urban areas (AOR=0.307, 95% CI: 0.127 - 0.742). Second-or higher-order births are associated with higher uptake of doses of PCV vaccinations (AOR=2.519, 95% CI: 1.143-5.548]). Compared to children born at home, children born in health facilities were 2.35 times more likely to receive greater doses of the PCV vaccination (AOR=2.350, 95% CI: 1.132-4.882). Children born from the women who received more ANC visits were significantly more likely to receive complete PCV coverage.
Conclusion: We observed a significant increase in the uptake of PCV vaccines across the two survey years even though Ethiopia is still far away from achieving national immunization goals. Our results also show that place of residence, birth order, place of delivery, ANC visits, and region were significantly associated with pneumococcal vaccine uptake.
Research Square Platform LLC
Title: Changes and determinants of pneumococcal vaccine uptake in Ethiopia
Description:
Abstract
Background:
Pneumococcal pneumonia is one of the most common causes of severe pneumonia and pneumonia-related mortality globally.
It is one of the top five causes of mortality and mortality in children under five in Ethiopia.
Vaccinating children reduced the disease burden of pneumonia and death-related pneumococcal infection for both child and adult populations.
Pneumococcal Pneumonia is one of the vaccine-preventable diseases.
Objective: To assess how pneumococcal vaccine uptake changes over time and to identify factors associated with uptake of the pneumococcal vaccine.
Data: This study was conducted based on secondary data obtained from the Ethiopian Demographic and Health Surveys (EDHS) conducted in 2016 and 2019, two nationally representative surveys.
A total of 1929 and 1008 children of aged 12–23 months were included res from the 2016 and 2019 Demographic and Health Surveys respectively.
Method: The Percentage change in pneumococcal vaccine (PCV) coverage was used to quantify the degree of change over time.
To identify the significant factors associated with the uptake of PCV vaccines, a multilevel ordinal logistic regression model was used.
All statistical tests were run with a significance threshold of 5%.
Result:The percentage of children aged 12-23 months who received complete doses of PCV vaccination increased from 49.
1% in 2016 to 59.
8% in 2019 with a significant 21.
8% increase [95% CI: 9.
8-35.
2].
Children in rural areas are 69% less likely to receive more doses of PCV vaccinations than those who live in urban areas (AOR=0.
307, 95% CI: 0.
127 - 0.
742).
Second-or higher-order births are associated with higher uptake of doses of PCV vaccinations (AOR=2.
519, 95% CI: 1.
143-5.
548]).
Compared to children born at home, children born in health facilities were 2.
35 times more likely to receive greater doses of the PCV vaccination (AOR=2.
350, 95% CI: 1.
132-4.
882).
Children born from the women who received more ANC visits were significantly more likely to receive complete PCV coverage.
Conclusion: We observed a significant increase in the uptake of PCV vaccines across the two survey years even though Ethiopia is still far away from achieving national immunization goals.
Our results also show that place of residence, birth order, place of delivery, ANC visits, and region were significantly associated with pneumococcal vaccine uptake.
Related Results
Factors associated with pneumococcal nasopharyngeal carriage: A systematic review
Factors associated with pneumococcal nasopharyngeal carriage: A systematic review
Pneumococcal disease is a major contributor to global childhood morbidity and mortality and is more common in low- and middle-income countries (LMICs) than in high-income countries...
89Factors associated with pneumococcal nasopharyngeal carriage: a systematic review
89Factors associated with pneumococcal nasopharyngeal carriage: a systematic review
Abstract
Background
Pneumococcal disease is a major contributor to global childhood morbidity and mortality. Pneumococcal carria...
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)
Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)
Introduction
In Canada, pneumococcal vaccination is recommended to all adults aged ≥65 and those <65 who have one or more chronic medical conditions (CMCs). Understanding vaccin...
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea ' s Claim 20/Ethiopia ' s Claim 8, Partial Awards; Economic Loss Throughout Ethiopia (Ethiopia v. Eritrea), Ethiopia ' s Claim 7, Partial Award; Jus ad Bellum (Ethiopia v. Eritrea), Ethiopia ' s Claims 1-8,
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea ' s Claim 20/Ethiopia ' s Claim 8, Partial Awards; Economic Loss Throughout Ethiopia (Ethiopia v. Eritrea), Ethiopia ' s Claim 7, Partial Award; Jus ad Bellum (Ethiopia v. Eritrea), Ethiopia ' s Claims 1-8,
Diplomatic Claims (Eritrea v. Ethiopia), Eritrea's Claim 20/Ethiopia's Claim 8, Partial Awards. At <http://www.pca-cpa.org>.Eritrea Ethiopia Claims Commission, December 19, 2...
Pneumococcal Serotypes in Urban Ugandan Children Vaccinated with the 10-Valent Pneumococcal Conjugate Vaccine
Pneumococcal Serotypes in Urban Ugandan Children Vaccinated with the 10-Valent Pneumococcal Conjugate Vaccine
Abstract
Objective
Uganda introduced the 10-valent pneumococcal conjugate vaccine (PCV10) into routine infant immunization in 2014, but post-int...
Abstract 13632: The Relationship Between Health Information Technology Use and Pneumococcal Vaccine Uptake in Adults With Heart Disease
Abstract 13632: The Relationship Between Health Information Technology Use and Pneumococcal Vaccine Uptake in Adults With Heart Disease
Introduction:
Health information technology (HIT) has been shown to influence medication adherence and healthy behaviors. This influence may increase the uptake of vacc...
Immunogenicity of Minhai 13-valent pneumococcal polysaccharide conjugate vaccine in experimental mice
Immunogenicity of Minhai 13-valent pneumococcal polysaccharide conjugate vaccine in experimental mice
Diseases caused by pneumococci are a global public health problem. The widespread use of antibiotics has led to a sharp increase in the drug resistance of pneumococci, making resea...

